In 2025, state-level Medicare Advantage plans show diverse trends, with 38% growing, 54% declining. Key states expand while others consolidate.
Explore 2025 Medicare Advantage trends, with plan counts dropping and Renewal Plans with SAR surging. Uncover new growth opportunities.
This report analyzes Medicare Advantage (MA) dynamics, highlighting UnitedHealth Group’s enrollment lead and CVS Health Corporation’s growth. State-level shifts show CVS Health as a dominant net enrollment player. The complex relationship between eligibility and enrollment underscores the market’s intricacies, offering valuable insights for strategic planning.
The 2024 Medicare Advantage market shows consolidation and selective growth, with membership at 33 million. Despite few new plans, states like Florida, Texas, and California remain prominent, while Indiana and Virginia emerge as competitors. Understanding these trends is vital for navigating healthcare’s evolving landscape.
In 2024, Medicare Advantage plans in the U.S. saw a rise in 4★ ratings, notably in PPO plans. CVS Health rebounded to 70% 4★ or higher. Sustainability trends varied across plan types and Payors.
In 2024, SSBCI benefits in Medicare Advantage plans show varied trends. Food Produce rises to 14.5%, while Home Modifications decline. HMO plans increase Food Produce and General Support, but Social Needs Quality decreases. PPO plans exhibit minor expansion.
Premium cost plays a pivotal role in Medicare Advantage plan choice, affecting expenses and benefits. We categorize premiums from $0 to over $300, offering insights into Supplemental and Enhanced benefits’ patterns based on CMS data.
This analysis delves into D-SNP Supplemental and Enhanced Benefits, unveiling trends in HMOs and PPOs. Benefits coverage shifts are evident, with Fitness and Remote Access Technologies playing pivotal roles in D-SNP plans.
Medicare Advantage (MA) plans offer diverse benefits, with trends varying in HMO and PPO plans. While some benefits remain steady, others show declines, indicating an evolving healthcare landscape.
The analysis of cost factors for 2024 reflects a conservative approach in Medicare Advantage. Zero-premium plans dominate, with modest growth. Drug deductibles fluctuate, influenced by regulatory changes. MOOP values remain stable, except for the >$6000 segment, which declined.
